James M. Frincke,Christopher L. Reading,Clarence N. Ahlem
申请号：
US13835995
公开号：
US20140010806A1
申请日:
2013.03.15
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention relates to methods to use 17α-ethynylandrost-5-ene-3β,7β,17β-triol to treat ocular diseases or conditions such as dry eye, uveitis or retinitis. The compound can be administered topically to the eye, by intravitreal injection or systemically, e.g., orally.
